Defining & exploiting mechanisms of resistance to nucleoside analogue hypomethylators in poor-risk haematological cancers

  • Shortt, Jake (Primary Chief Investigator (PCI))
  • Kats, Lev (Chief Investigator (CI))

Project: Research

Project Details

StatusFinished
Effective start/end date1/01/20 → 31/12/22

Keywords

  • leukaemia
  • lymphoma
  • DNA methylation
  • drug resistance
  • epigenetics